Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Healthware Group appoints Yannick Valenti as digital strategy and customer engagement director

Prior to Healthware, Valenti spent three years at Ogilvy Health as digital strategy director

- PMLiVE

Lucid Group promotes Clare Reynolds to newly created role

Reynolds initially joined Lucid in 2009 as business unit director

- PMLiVE

Corin Baird joins Havas Just:: as head of digital

Baird joins the team with a varied background in digital marketing

- PMLiVE

Strategy experts: the real thing

What defines genuine strategy experts in the biomedical industry?

- PMLiVE

Versiti launches test for vaccine-related blood clot issues

Launch follows reports of very rare blood clots connected to J&J's vaccine

- PMLiVE

Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics

Drug could treat life-threatening antifungal-resistant infections

- PMLiVE

GSK’s revenue drops by 18% in Q1 as performance pressures mount

Chief executive Emma Walmsley said results ‘reflect the anticipated impacts of COVID-19’

- PMLiVE

Novartis announces delay in UK cholesterol drug study

The delay was caused by recruitment issues during the COVID-19 pandemic

- PMLiVE

ICR appoints Kristian Helin as its new chief executive

Helin will join ICR in September from the Memorial Sloan Kettering Cancer Center in the US

- PMLiVE

Lilly cuts 2021 guidance to reflect ‘lower expected revenue’ from COVID-19 antibody sales

FDA recently removed emergency authorisation for bamlanivimab monotherapy

- PMLiVE

Pfizer CEO says oral COVID-19 pill could be ready by the end of the year

Company initiated a phase 1 study of the drug last month

- PMLiVE

FDA panel votes to keep accelerated approval for Roche’s Tecentriq in breast cancer

Oncologic Drugs Advisory Committee voted seven to two in favour of drug

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links